386 related articles for article (PubMed ID: 34830210)
1. Misfolded G Protein-Coupled Receptors and Endocrine Disease. Molecular Mechanisms and Therapeutic Prospects.
Ulloa-Aguirre A; Zariñán T; Jardón-Valadez E
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830210
[TBL] [Abstract][Full Text] [Related]
2. Targeting trafficking as a therapeutic avenue for misfolded GPCRs leading to endocrine diseases.
Ulloa-Aguirre A; Zariñán T; Gutiérrez-Sagal R; Tao YX
Front Endocrinol (Lausanne); 2022; 13():934685. PubMed ID: 36093106
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological chaperones correct misfolded GPCRs and rescue function: protein trafficking as a therapeutic target.
Maya-Núñez G; Ulloa-Aguirre A; Janovick JA; Conn PM
Subcell Biochem; 2012; 63():263-89. PubMed ID: 23161143
[TBL] [Abstract][Full Text] [Related]
4. Mutations in G protein-coupled receptors that impact receptor trafficking and reproductive function.
Ulloa-Aguirre A; Zariñán T; Dias JA; Conn PM
Mol Cell Endocrinol; 2014 Jan; 382(1):411-423. PubMed ID: 23806559
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological chaperones for misfolded gonadotropin-releasing hormone receptors.
Conn PM; Ulloa-Aguirre A
Adv Pharmacol; 2011; 62():109-41. PubMed ID: 21907908
[TBL] [Abstract][Full Text] [Related]
6. Intracellular Trafficking of Gonadotropin Receptors in Health and Disease.
Ulloa-Aguirre A; Zariñán T; Gutiérrez-Sagal R; Dias JA
Handb Exp Pharmacol; 2018; 245():1-39. PubMed ID: 29063275
[TBL] [Abstract][Full Text] [Related]
7. Trafficking of G-protein-coupled receptors to the plasma membrane: insights for pharmacoperone drugs.
Conn PM; Ulloa-Aguirre A
Trends Endocrinol Metab; 2010 Mar; 21(3):190-7. PubMed ID: 20005736
[TBL] [Abstract][Full Text] [Related]
8. Targeting of G protein-coupled receptors to the plasma membrane in health and disease.
Ulloa-Aguirre A; Conn PM
Front Biosci (Landmark Ed); 2009 Jan; 14(3):973-94. PubMed ID: 19273112
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological chaperone action on G-protein-coupled receptors.
Bernier V; Bichet DG; Bouvier M
Curr Opin Pharmacol; 2004 Oct; 4(5):528-33. PubMed ID: 15351360
[TBL] [Abstract][Full Text] [Related]
10. Regulation of G protein-coupled receptor export trafficking.
Dong C; Filipeanu CM; Duvernay MT; Wu G
Biochim Biophys Acta; 2007 Apr; 1768(4):853-70. PubMed ID: 17074298
[TBL] [Abstract][Full Text] [Related]
11. Pharmacoperones: a new therapeutic approach for diseases caused by misfolded G protein-coupled receptors.
Ulloa-Aguirre A; Michael Conn P
Recent Pat Endocr Metab Immune Drug Discov; 2011 Jan; 5(1):13-24. PubMed ID: 22074574
[TBL] [Abstract][Full Text] [Related]
12. G protein-coupled receptor trafficking in health and disease: lessons learned to prepare for therapeutic mutant rescue in vivo.
Conn PM; Ulloa-Aguirre A; Ito J; Janovick JA
Pharmacol Rev; 2007 Sep; 59(3):225-50. PubMed ID: 17878512
[TBL] [Abstract][Full Text] [Related]
13. Pharmacoperones for Misfolded Gonadotropin Receptors.
Newton CL; Anderson RC
Handb Exp Pharmacol; 2018; 245():111-134. PubMed ID: 29043503
[TBL] [Abstract][Full Text] [Related]
14. Functional Rescue of Inactivating Mutations of the Human Neurokinin 3 Receptor Using Pharmacological Chaperones.
Anderson RC; Hanyroup S; Song YB; Mohamed-Moosa Z; van den Bout I; Schwulst AC; Kaiser UB; Millar RP; Newton CL
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562976
[TBL] [Abstract][Full Text] [Related]
15. Use of pharmacoperones to reveal GPCR structural changes associated with constitutive activation and trafficking.
Janovick JA; Conn PM
Methods Enzymol; 2010; 485():277-92. PubMed ID: 21050923
[TBL] [Abstract][Full Text] [Related]
16. G protein-coupled receptors disrupted in human genetic disease.
Thompson MD; Percy ME; McIntyre Burnham W; Cole DE
Methods Mol Biol; 2008; 448():109-37. PubMed ID: 18370233
[TBL] [Abstract][Full Text] [Related]
17. G protein-coupled receptor mutations and human genetic disease.
Thompson MD; Hendy GN; Percy ME; Bichet DG; Cole DE
Methods Mol Biol; 2014; 1175():153-87. PubMed ID: 25150870
[TBL] [Abstract][Full Text] [Related]
18. Trafficking-defective mutant PROKR2 cycles between endoplasmic reticulum and Golgi to attenuate endoplasmic reticulum stress.
Song YB; Park SY; Park K; Hwang H; Carroll RS; Hsu VW; Kaiser UB
Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35173048
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological Chaperones as Potential Therapeutic Strategies for Misfolded Mutant Vasopressin Receptors.
Mouillac B; Mendre C
Handb Exp Pharmacol; 2018; 245():63-83. PubMed ID: 28939971
[TBL] [Abstract][Full Text] [Related]
20. Pharmacoperone drugs: targeting misfolded proteins causing lysosomal storage-, ion channels-, and G protein-coupled receptors-associated conformational disorders.
Hou ZS; Ulloa-Aguirre A; Tao YX
Expert Rev Clin Pharmacol; 2018 Jun; 11(6):611-624. PubMed ID: 29851355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
